Intrinsiqs

Is Context Therapeutics Inc. overvalued?

Context Therapeutics Inc. (CNTX) — key valuation metrics and fundamentals.

No verdict
Price
$0.62
Fair value
Current P/E
Normal P/E
Market cap
$56.6M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares CNTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 1 Jul 2026.